Epitomee slumps as Nestle nixes marketing weight loss pill
Nestlé says the trial results did not meet the full minimal terms set in the licensing agreement.
Source: globes.co.il
Stay updated with breaking news from Doron Marco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nestlé says the trial results did not meet the full minimal terms set in the licensing agreement.
The Israeli company has developed a pill that swells in the stomach, creates a sense of satiation and then disintegrates.
The flotation is Eckhouse's second in six months. Epitomee has developed a pill for treating obesity and drug delivery.